FdaApplication
NDA 211413
Identifiers
- fda_app_no: NDA211413
Properties
| Property | Value |
|---|---|
| applicant_name | HQ SPECIALTY PHARMA CORP |
| application_type | NDA |
| approval_date | 2023-05-08 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CEFAZOLIN SODIUM | CEFAZOLIN SODIUM | EQ 2GM BASE/VIAL | POWDER;INTRAVENOUS |
| CEFAZOLIN SODIUM | CEFAZOLIN SODIUM | EQ 3GM BASE/VIAL | POWDER;INTRAVENOUS |
2 products